Biotech firm Neurxstem launches joint venture with UK to tackle Alzheimer’s, autism, addiction, and age-related cognitive decline using innovative brain health technology
The Behavioral Health Tech conference is expanding its focus to include autism and neurodiversity, recognizing the needs of this often-overlooked community in behavioral health care.
